Macrophage Pharma

Macrophage Pharma is an immuno-oncology company focussed on the discovery and development of novel therapies designed to enhance anti-tumour immune responses.
Macrophage Pharma’s technology platform is designed to deliver small molecule drugs to tumour associated macrophages in a highly selective manner to activate the body’s natural immune system to fight cancer.

Team Members
more about
Hakan Goker
more about
Alicia Irurzun-Lafitte
more about
Cheryl Zimberlin
Latest News Entry
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures

Merck Ventures Joins Investment Syndicate and the Board of Macrophage

all portfolio news